Abstract
Increased delivery of circulating free fatty acids (FFA) to the liver has been implicated in the pathogenesis and progression of diabetes. The liver is inaccessible for direct measurement in humans in vivo. We measured liver FFA uptake with positron emission tomography (PET) and 14(R,S)-[18F]fluoro-6-thia-heptadecanoic acid ([18F]FTHA) in healthy men. We evaluated the use of graphical analysis and linear fit to describe uptake data over time, and compared the use of metabolite-corrected vs uncorrected input functions. Rapid accumulation of tracer in the liver was observed with time, leading to progressively higher tissue to blood radioactivity ratios. Using metabolite-corrected input function curves, linear fit to the data (r value) exceeded 0.99 in all subjects, during each fitting time frame. Values of liver FFA influx rate constant and uptake were 0.34±0.01 ml min−1 ml−1 and 0.20±0.02 µmol min−1 ml−1, respectively, and were minimally affected by the choice of the fitting interval. Expressed per unit mass, liver FFA uptake was ~50 times higher than that reported in skeletal muscle; in the whole organ, FFA uptake was twice as high as in skeletal muscles. The use of metabolite-uncorrected input functions significantly worsened the spread of data around the fitted line and led to a remarkable underestimation of liver FFA uptake at all time intervals. In conclusion, our data provide non-invasive quantification of hepatic FFA uptake in humans, showing the liver to handle a high FFA flux. [18F]FTHA-PET appears a valuable tool for the investigation of hepatic FFA turnover in humans.
References
DeFronzo RA. Lilly lecture 1987. The triumvirate: beta-cell, muscle, liver. a collusion responsible for NIDDM. Diabetes 1988; 37:667–687.
McGarry JD. Dysregulation of fatty acid metabolism in the etiology of type 2 diabetes. Diabetes 2002; 51:7–18.
Seppala-Lindroos A, Vehkavaara S, Hakkinen AM, Westerbacka J, Sovijarvi A, halavaara J, Yki-Jarvinen H. Fat accumulation in the liver is associated with defects in insulin suppression of glucose production and serum free fatty acids independent of obesity in normal men. J Clin Endocrinol Metab 2002; 87:3023–3028.
Shah P, Vella A, Basu A, Basu R, Adkins A, Schwenk WF, Johnson CM, Nair KS, Jensen MD, Rizza R. Effects of free fatty acids and glycerol on splanchnic glucose metabolism and insulin extraction in nondiabetic humans. Diabetes 2002; 51:301–310.
DeFronzo RA. Use of the splanchnic/hepatic balance technique in the study of glucose metabolism. Baillieres Clin Endocrinol Metab 1987; 1:837–862.
Sidossis LS, Mittendorfer B, Chinkes D, Walser E, Wolfe RR. Effect of hyperglycemia-hyperinsulinemia on whole body and regional fatty acid metabolism. Am J Physiol Endocrinol Metab 1999; 276:E427–E434.
Hagenfeldt L, Wahren J, Pernow B, Raf L. Uptake of individual free fatty acids by skeletal muscle and liver in man. J Clin Invest 1972; 51:2324–2330.
Turpeinen AK, Takala TO, Nuutila P, Axelin T, Luotolahti M, Haaparanta M, Bergman J, Hamalainen H, Iida H, Maki M, Uusitupa MIJ, Knuuti J. Impaired free fatty acid uptake in skeletal muscle but not in myocardium in patients with impaired glucose tolerance. Studies with PET and 14(R,S)-[18F]-fluoro-6-thia-heptadecanoic acid. Diabetes 1999; 48:1245–1250.
Van den Hoff J, Burchert W, Muller-Schauenburg W, Meyer GJ, Hundeshagen H. Accurate local blood flow measurements with dynamic PET: fast determination of input function delay and dispersion by multilinear minimization. J Nucl Med 1993; 34:1770–1777.
Patlak CS, Blasberg RG. Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. Generalizations. J Cereb Blood Flow Metab 1985; 5:584–590.
Basso LV, Havel R. Hepatic metabolism of free fatty acids in normal and diabetic dogs. J Clin Invest 1970; 19:537–547.
Richardson PD, Withrington PG. Liver blood flow. I. Intrinsic and nervous control of liver blood flow. Gastroenterology 1981; 81:159–173.
Richardson PD, Withrington PG. Liver blood flow. II. Effects of drugs and hormones on liver blood flow. Gastroenterology 1981; 81:356–375.
Takala TO, Nuutila P, Pulkki K, Oikonen V, Gronroos T, Savunen T, Vahasilta T, Luotolahti M, Kallajoki M, Bergman J, Forsback S, Knuuti J. 14(R,S)-[18F]-fluoro-6-thia-heptadecanoic acid as a tracer of free fatty acid uptake and oxidation in myocardium and skeletal muscle. Eur J Nucl Med 2002; 29:1617–1622.
Skrede S, Narce M, Bergseth S, Bremer J. The effects of alkylthioacetic acids (3-thia fatty acids) on fatty acid metabolism in isolated hepatocytes. Biochim Biophys Acta 1989; 1005:296–302.
Knust EJ, Kupfernagel C, Stocklin G. Long-chain F-18 fatty acids for the study of regional metabolism in heart and liver; odd-even effects of metabolism in mice. J Nucl Med 1979; 20:1170–1175.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Iozzo, P., Turpeinen, A.K., Takala, T. et al. Liver uptake of free fatty acids in vivo in humans as determined with 14(R,S)-[18F]fluoro-6-thia-heptadecanoic acid and PET. Eur J Nucl Med Mol Imaging 30, 1160–1164 (2003). https://doi.org/10.1007/s00259-003-1215-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00259-003-1215-0